Evotec
Tracked across 16 events · 597 articles · First seen Apr 01, 2026 · Last active Aug 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Evotec has nominated Dieter Weinand as the new Chairman of its Supervisory Board, aiming to strengthen commercial execution, strategic partnerships, and profitability. This move is part of Evotec's transformation into a more efficient and focused company.
Apr 07, 2026 · 9 articles
Business
Impact: Evotec appointed Dr. Ingrid Müller as its Chief Operating Officer, which is expected to strengthen its global operations and growth transformation.
Apr 15, 2026 · 7 articles
Regulatory
Impact: Evotec SE is the issuer of the shares whose voting rights are being reported. The changes in holdings by Goldman Sachs>>> affect the ownership structure of Evotec>>>.
Apr 02, 2026 · 38 articles
Tech
Impact: Evotec SE launched J.TRAIN, a new service offering through its wholly-owned subsidiary Evotec — Just – Evotec Biologics, which is expected to increase its revenue streams and market position in biologics manufacturing. This strategic expansion validates its technology licensing model and enhances its service portfolio.
Jun 30, 2026 · 7 articles
Business
Impact: Evotec appointed Wang Rui>>> as Executive Vice President, Head of Global In Silico and AI, aiming to strengthen its AI-driven drug discovery and development capabilities. This appointment is expected to enhance Evotec>>>'s innovation and operational efficiency.
Jun 02, 2026 · 8 articles
Business
Impact: Evotec held its Annual General Meeting, where shareholders adopted all agenda items and elected new members to its Supervisory Board, including a new Chairman. This event impacts Evotec's corporate governance and strategic direction.
Jun 11, 2026 · 7 articles
Business
Impact: Evotec is the subject of the announcement; its lowered revenue and EBITDA guidance indicate financial underperformance, negatively affecting investor confidence.
Jul 13, 2026 · 7 articles
Business
Impact: Evotec is a key partner providing its AI-enabled discovery platform and screening capabilities. The collaboration could generate milestone payments and strengthen its position in AI-driven drug discovery.
Aug 06, 2026 · 6 articles
Regulatory
Evotec, a Hamburg-based drug discovery and development company, has been the subject of multiple voting rights notifications under the German Securities Trading Act (WpHG). Goldman Sachs, Inc. and JPMorgan Chase & Co. have disclosed changes…
Impact: Evotec is the issuer subject to the voting rights notifications. The disclosures reflect changes in its shareholder structure but do not indicate any operational or strategic changes.
Jun 30, 2026 · 20 articles
Accidents
Impact: Evotec Biologics is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
Tech
Impact: Evotec was among the organizations whose researchers co-authored the publication.
Jun 11, 2026 · 10 articles
100
Goldman Sachs changed voting rights EvotecGoldman Sachs adjusts Evotec stake
90
Goldman Sachs changed voting rights EvotecGoldman and JPMorgan...
80
JPMorgan Chase changed voting rights EvotecGoldman and JPMorgan...
Christian Wojczewski
ceo
↔
Evotec
Christian Wojczewski is the Chief Executive Officer and Chairman of the Manageme
ERGEN INTELLIGENCE
Track Evotec live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard